Also trades as: 4528.T (JPX) · $vol 23M · OPHLY (OTC) · $vol 0M

$14.95

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 52 · $7.0B mcap · 333M float · 0.0003% daily turnover · Short 51% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$519.0B +6.6% ▲

5Y CAGR: +10.9%

Gross Profit

$376.4B +11.1% ▲

5Y CAGR: +11.0%

Operating Income

$104.0B +74.0% ▲

5Y CAGR: +1.1%

Net Income

$70.2B +40.3% ▲

5Y CAGR: -1.4%

EPS (Diluted)

$148.60 +39.6% ▲

5Y CAGR: -0.3%

EBITDA

$142.0B +55.1% ▲

5Y CAGR: +4.4%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$361.4B	$447.2B	$502.7B	$486.9B	$519.0B
YoY Growth	+16.8%	+23.8%	+12.4%	-3.1%	+6.6%
Cost of Revenue	$93.5B	$110.1B	$127.1B	$147.9B	$142.6B
Gross Profit	$267.9B	$337.1B	$375.5B	$338.9B	$376.4B
Gross Margin	74.1%	75.4%	74.7%	69.6%	72.5%
R&D Expenses	$75.9B	$95.3B	$112.4B	$149.9B	$148.0B
SG&A Expenses	$74.1B	$86.6B	$97.4B	$122.2B	$123.7B
Operating Expenses	$152.9B	$184.8B	$212.4B	$279.2B	$272.4B
Operating Income	$114.9B	$152.3B	$163.1B	$59.7B	$104.0B
Operating Margin	31.8%	34.1%	32.4%	12.3%	20.0%
Interest Expense	$874M	$913M	$229M	$5.3B	$3.6B
Income Before Tax	$105.0B	$143.5B	$163.7B	$59.3B	$93.2B
Tax Expense	$24.3B	$30.6B	$35.7B	$9.2B	$22.9B
Net Income	$80.5B	$112.7B	$128.0B	$50.0B	$70.2B
Net Margin	22.3%	25.2%	25.5%	10.3%	13.5%
EPS (Diluted)	$162.16	$230.79	$266.60	$106.41	$148.60
EBITDA	$128.5B	$167.5B	$178.4B	$91.5B	$142.0B
Shares Outstanding	497M	488M	480M	470M	470M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$117.7B	$122.7B	$134.2B	$112.3B	$127.5B	$131.5B	$140.0B	$119.5B
Cost of Revenue	$29.7B	$27.2B	$45.8B	$45.2B	$37.0B	$35.5B	$36.7B	$33.3B
Gross Profit	$88.0B	$95.5B	$88.4B	$67.1B	$90.5B	$96.0B	$103.3B	$86.2B
Gross Margin	74.8%	77.8%	65.9%	59.7%	71.0%	73.0%	73.8%	72.2%
R&D Expenses	$28.9B	$39.9B	$38.3B	$42.8B	$36.3B	$35.3B	$33.6B	$42.8B
SG&A Expenses	$27.9B	$30.5B	$35.3B	$31.9B	$31.1B	$30.5B	$31.8B	$31.0B
Operating Expenses	$57.3B	$69.9B	$73.5B	$78.1B	$68.5B	$65.8B	$65.3B	$73.7B
Operating Income	$30.7B	$25.5B	$14.9B	-$11.0B	$22.0B	$30.2B	$38.0B	$12.5B
Operating Margin	26.1%	20.8%	11.1%	-9.8%	17.2%	23.0%	27.1%	10.5%
Interest Expense	$75M	$3.9B	$0	$1.8B	$5M	$1.2B	$408M	$1.1B
Income Before Tax	$33.3B	$21.3B	$17.4B	-$12.7B	$22.6B	$29.9B	$37.2B	$3.3B
Tax Expense	$8.5B	$4.5B	$2.5B	-$6.3B	$5.0B	$7.3B	$8.3B	$2.3B
Net Income	$24.8B	$16.8B	$15.0B	-$6.5B	$17.7B	$22.8B	$28.9B	$823M
Net Margin	21.1%	13.7%	11.1%	-5.8%	13.9%	17.4%	20.6%	0.7%
EPS (Diluted)	$52.75	$35.82	$31.81	$-13.90	$37.58	$48.39	$61.47	$1.73
EBITDA	$35.1B	$29.8B	$24.0B	-$5.8B	$31.2B	$40.6B	$47.2B	$22.2B
Shares Outstanding	470M	470M	470M	470M	470M	470M	470M	477M

OPHLF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet